Biomarkers Market Research Reports & Industry Analysis
Biomarkers are measurable indicators, such as molecules or genetic mutations, that provide information about a biological process, condition, or disease in the body. As healthcare evolves, it's important to grasp the impact and unique dynamics of this industry. At MarketResearch.com, we understand the need for reliable data on this sector. Our biomarkers market research reports provide a comprehensive and informative analysis, empowering you to navigate this dynamic industry with greater confidence.
Biomarkers Industry Insights
- Our research covers diverse markets so you can quickly and easily find research on segments big and small.
- Through our platform, you can access essential data to drive strategic decisions, from biomarkers market sizing and growth projections to key drivers and challenges.
- Use our research to better understand products under development, market trends, competitor analysis, and leading players.
Harnessing MarketResearch.com's Expertise
For more than twenty years, MarketResearch.com has been a leader in the field of market research, serving a diverse clientele that includes top investment banks, management consulting firms, and multinational corporations. We are known for providing reliable insights and offer a centralized platform with access to reports from numerous firms. In addition, our research specialists are available to provide expert guidance and support every step of the way.
Biomarkers Industry Research & Market Reports
-
Global Liquid Biopsy Market 2024-2028
... biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, ... Read More
-
Neurological Biomarkers Market, By Biomarker Type (Artificial Tears, Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers), By Application (Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Neurological biomarkers help in objectively measuring and evaluating normal biological and pathogenic processes. These aid in detecting ... Read More
-
Cardiac Biomarkers Market, By Product Type (Myocardial Muscle Creatine Kinase, Myoglobin, Troponins, Brain Natriuretic Peptide or NT-proBNP, Ischemia-modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Cardiac biomarkers refer to proteins that are present in blood when ... Read More
-
2024 Malaysia Tumor Marker Diagnostics Market Opportunities - Competitive Shares and Growth Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
... Market Barriers and Risks This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights ... Read More
-
Global Digital Biomarker Competitive Landscape Professional Research Report 2024
... track health-related information, disease progression, treatment outcomes, and overall well-being. Digital biomarkers have the potential to provide continuous, real-time data, allowing for more comprehensive insights compared to traditional sporadic clinical assessments. They can include parameters ... Read More
-
Global PD-L1 Biomarker Testing Competitive Landscape Professional Research Report 2024
... expression on the surface of cancer cells. It plays a crucial role in the field of cancer immunotherapy, particularly in the treatment of solid tumors with immune checkpoint inhibitors. The test involves analyzing tissue samples ... Read More
-
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Competitive Landscape Professional Research Report 2024
... biomarkers that can be used in various medical contexts. Biomarkers are measurable indicators found in biological samples, such as blood, urine, or tissue, that can signal the presence or progression of diseases or provide insights ... Read More
-
Global Biomarkers Competitive Landscape Professional Research Report 2024
... an organism. They can be found in bodily fluids, tissues, or other biological samples and can provide valuable information about the presence, progression, or severity of a disease, as well as the efficacy of a ... Read More
-
Exosome Research Market Assessment, By Product and Service [Kits and Reagents, Instruments, Services], By Indication Type [Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Others], By Application Type [Biomarkers, Vaccine Development, Tissue Regeneration, Others], By End-user [Pharmaceutical and Biotechnological Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F
... End-user [Pharmaceutical and Biotechnological Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F Global exosome research market is projected to witness a CAGR of 17.37% during the forecast ... Read More
-
Global Neurological Biomarkers Competitive Landscape Professional Research Report 2024
... various physiological, biochemical, or imaging-based measurements that are associated with normal neurological function or specific neurological conditions or diseases. Examples of neurological biomarkers include specific proteins or molecules found in cerebrospinal fluid or blood, abnormalities ... Read More
-
Genomic Biomarker Market by Product (Consumables, Services, Software), Type (Predictive Biomarkers, Prognostic Biomarkers), Disease Indication, End-User - Global Forecast 2024-2030
... expected to reach USD 4.67 billion in 2024, at a CAGR 6.67% to reach USD 6.92 billion by 2030. Genomic biomarkers are DNA or RNA molecules that are used to examine the complex relationships between ... Read More
-
Cancer Biomarkers Market by Biomarker Type (Genetic, Protein), Cancer Type (Blood Cancer, Breast Cancer, Colorectal Cancer), Technology, Application, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 31.23 billion in 2024, at a CAGR 10.71% to reach USD 57.75 billion by 2030. Cancer biomarkers are substances or processes that can be measured in parts ... Read More
-
Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Global Forecast 2024-2030
... 2023 and expected to reach USD 4.16 billion in 2024, at a CAGR 9.71% to reach USD 7.29 billion by 2030. Cardiac markers are substances or molecules measured in the blood to diagnose and monitor ... Read More
-
Cardiac Point of Care Testing Market by Product (Analyzers, Kits & Assays, Software & Services), Biomarker Type (Cardiac Troponins, CK-MB Fraction, D-Dimer), End-User - Global Forecast 2024-2030
... size was estimated at USD 8.31 billion in 2023 and expected to reach USD 9.38 billion in 2024, at a CAGR 13.14% to reach USD 19.74 billion by 2030. Cardiac point of care testing refers ... Read More
-
Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030
... USD 3.11 billion in 2023 and expected to reach USD 3.38 billion in 2024, at a CAGR 9.25% to reach USD 5.78 billion by 2030. A central lab operates as a core facility providing high-quality ... Read More
-
Biomarker Testing Services Market by Services (Biomarker Assay Development & Validation, Flow Cytometry), Techonology (Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing), Disease Area, Application, End-User - Global Forecast 2024-2030
... size was estimated at USD 964.90 million in 2023 and expected to reach USD 1,031.96 million in 2024, at a CAGR 7.34% to reach USD 1,585.04 million by 2030. Biomarker testing services refer to the ... Read More
-
Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Global Forecast 2024-2030
... USD 5.10 billion in 2023 and expected to reach USD 5.50 billion in 2024, at a CAGR 7.90% to reach USD 8.69 billion by 2030. Cardiac marker testing market consists of the spectrum of medical ... Read More
-
Cancer/Tumor Profiling Market by Technology (Immunoassays, In-Situ Hybridization, Mass Spectrometry), Biomarker Type (Genomic Biomarker, Protein Biomarker), Cancer Type, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 12.77 billion in 2024, at a CAGR 18.74% to reach USD 35.94 billion by 2030. Cancer/tumor profiling is a laboratory method that analyzes specific proteins, genes, and other ... Read More
-
Biomarkers Market by Product & Service (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease, Application - Global Forecast 2024-2030
... and expected to reach USD 59.69 billion in 2024, at a CAGR 14.19% to reach USD 132.98 billion by 2030. Biomarkers, also known as biological markers, a measurable indicators of some biological state or condition, ... Read More
-
GI Stool Testing Market by Product (Analyzers, Consumables), Test (Bacteria Test, Fecal Biomarkers Test, Occult Blood Test), Application, End-use - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 691.83 million in 2024, at a CAGR 6.67% to reach USD 1,024.26 million by 2030. The GI (Gastrointestinal) stool testing market involves the analysis of fecal samples ... Read More
-
Global Biomarker of Disease Market Growth (Status and Outlook) 2024-2030
... and other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation ... Read More
-
Cancer Biomarker Global Market Opportunities And Strategies To 2033
... Prognostics; Risk Assessment4) By Cancer Type: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach CancerCovering: Roche Diagnostics; Novartis AG; Illumina; Hologic Inc.; ... Read More
-
Global Veterinary Biomarker Test Product Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Veterinary Biomarker Test Product is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the ... Read More
-
U.S. Non-alcoholic Steatohepatitis Biomarkers Market Size, Share & Trends Analysis Report By Type (Serum, Hepatic Fibrosis, Apoptosis), By End-use (Hospitals, Diagnostic Labs), And Segment Forecasts, 2024 - 2030
... & Trends The U.S. non-alcoholic steatohepatitis biomarkers market size is anticipated to reach USD 2.84 billion by 2030 and is anticipated to expand at a CAGR of 23.9% from 2024 to 2030, according to a ... Read More
-
Liquid Biopsy Market Share, Size, Trends, & Industry Analysis Report, By Technology (PCR Microarrays, NGS); By Sample Type (Blood, Urine, Saliva, Other Body Fluid); By Biomarker (Exosomes, CTC, ctDNA); By Application; By Region and Segment Forecast, 2024-2032
... Segment Forecast, 2024-2032 The global liquid biopsy market size is slated to reach USD 28.52 billion by 2032 at a CAGR of 10.9% according to a news report published by Polaris Market Research. The report ... Read More
Research Assistance
